Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 311 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al..  2019.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.
Vina ER, Hannon MJ, Masood H, Hausmann LRM, Ibrahim SA, Dagnino J, Arellano A, C Kwoh K.  2019.  Non-steroidal Anti-inflammatory Drug Use in Chronic Arthritis Pain: Variations by Ethnicity.. Am J Med.
Murthy SB, Wu X, Díaz I, Parasram M, Parikh NS, Iadecola C, Merkler AE, Falcone GJ, Brown S, Biffi A et al..  2020.  Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.. Stroke. 51(5):1464-1469.
Murthy SB, Wu X, Díaz I, Parasram M, Parikh NS, Iadecola C, Merkler AE, Falcone GJ, Brown S, Biffi A et al..  2020.  Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.. Stroke. 51(5):1464-1469.
O
Goyal P, Ringel JBryan, Rajan M, Choi JJ, Pinheiro LC, Li HA, Wehmeyer GT, Alshak MN, Jabri A, Schenck EJ et al..  2020.  Obesity and COVID-19 in New York City: A Retrospective Cohort Study.. Ann Intern Med.
Flory JH, Mushlin AI.  2015.  Observational and clinical trial findings on the comparative effectiveness of diabetes drugs showed agreement.. J Clin Epidemiol. 68(2):200-10.
Turchioe MReading, Grossman LV, Baik D, Lee CS, Maurer MS, Goyal P, Safford MM, Creber RMMasterso.  2020.  Older Adults Can Successfully Monitor Symptoms Using an Inclusively Designed Mobile Application.. J Am Geriatr Soc.
Doraiswamy S, Cheema S, Mamtani R.  2020.  Older people and epidemics: a call for empathy.. Age Ageing. 49(3):493.
Aviki EM, Schleicher SM, Mullangi S.  2019.  The Oncology Care Model and Other Value-Based Payment Models in Cancer Care.. JAMA Oncol. 5(3):298-299.
Mones E, Stopczynski A, Pentland A'Sandy', Hupert N, Lehmann S.  2018.  Optimizing targeted vaccination across cyber-physical networks: an empirically based mathematical simulation study.. J R Soc Interface. 15(138)
Feng Z, Jung H-Y, Wright B, Mor V.  2014.  The origin and disposition of Medicare observation stays.. Med Care. 52(9):796-800.
Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP.  2019.  Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.. Drug Alcohol Depend. 200:34-39.
P
McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, Alexander JA.  2016.  Patient-Centered Medical Home Adoption: Results From Aligning Forces For Quality.. Health Aff (Millwood). 35(1):141-9.
Meinhofer A.  2020.  Pediatric Implications of Opioid-Specific Parental Drug Use-Reply.. JAMA Pediatr.
Mullangi S, Bhandari R, Thanaporn P, Christensen M, Kronick S, Nallamothu BK.  2020.  Perceptions of resuscitation care among in-hospital cardiac arrest responders: a qualitative analysis.. BMC Health Serv Res. 20(1):145.
Pesko MF, Xu X, Tynan MA, Gerzoff RB, Malarcher AM, Pechacek TF.  2014.  Per-pack price reductions available from different cigarette purchasing strategies: United States, 2009-2010.. Prev Med. 63:13-9.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al..  2019.  A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.  2019.  A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Chaabane S, Chaabna K, Abraham A, Mamtani R, Cheema S.  2020.  Physical activity and sedentary behaviour in the Middle East and North Africa: An overview of systematic reviews and meta-analysis.. Sci Rep. 10(1):9363.
Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, Mendelsohn J, Moody J.  2015.  Physician Networks and Ambulatory Care-sensitive Admissions.. Med Care. 53(6):534-41.